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A b s T r A C T
background: Patients with hairy cell leukaemia (HCl) 
have an increased susceptibility to intracellular pathogens, 
such as mycobacteria and Listeria. Although several 
abnormalities of T-cell populations have been described in 
HCl, the effector mechanism responsible for the increased 
susceptibility to infections is not known. 
Methods: blood was collected from 11 patients with 
HCl and 22 age- and gender-matched volunteers. 
Proinflammatory cytokine production by freshly isolated 
mononuclear cells was stimulated with either lipopoly-
saccharide or various heat-killed microorganisms. Cytokine 
concentrations were assessed by specific ElisAs.
results: We demonstrate that mononuclear cells harvested 
from HCl patients have a specific defect of ifNγ production 
when stimulated with a broad panel of bacterial stimuli. 
in contrast, the production of other proinflammatory 
cytokines, such as TNf, il-1β and il-6, did not differ 
between HCl patients and controls. 
Conclusion: The specific defect in ifNγ production may 
play a role in the susceptibility of patients with hairy cell 
leukaemia towards intracellular pathogens.
K E Y W o r d s
Cytokines, hairy cell leukaemia, interferon-gamma, 
mycobacteria
i N T r o d U C T i o N
Hairy cell leukaemia (HCL) is a chronic B-lymphocyte 
malignancy, in which mature neoplastic B lymphocytes 
show hair-like protrusions.1 A major characteristic of HCL 
is splenomegaly, due to accumulation of malignant cells. In 
HCL, opportunistic infections, especially with facultative 
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intracellular pathogens such as mycobacteria or Listeria, are 
prominent.2 The occurrence of these infections suggests a 
serious defect in the cellular immune defence provided by 
T lymphocytes and macrophages.3
Although HCL is a B-cell malignancy, a series of abnormalities 
in the function of T cells have been also reported. There is 
abnormal T-cell activation, proliferation, clonal expansion and 
distribution; there is a decrease in memory T helper cells, an 
increase in splenic CD3-positive T cells positive for gamma 
delta T-cell receptors, and a restricted and skewed repertoire 
of the T-cell receptor family.4-7 Although these abnormalities 
all point to T-lymphocyte dysfunction, the exact mechanism 
behind the increased susceptibility to facultative intracellular 
infection is not clear.
In recent years, an increased susceptibility to mycobacteria 
and Salmonella species has been described in patients with 
genetic defects in the interleukin-12/interferon-gamma 
(IL-12, IFNγ) macrophage activation route.8 In these patients, 
the defects result in impaired IFNγ signalling, required to 
activate the microbicidal capacity of macrophages.
In the present study we have assessed the production of 
IFNγ by peripheral blood cells of patients with HCL, to 
obtain a better insight into the effector arm of cellular 
immunity in this disease. Since cytokines other than IFNγ 
are also relevant for host defence against infection, and 
cytokine production is regulated within what is known 
as the cytokine network, we measured a series of other 
relevant proinflammatory cytokines. 
P A T i E N T s  A N d  M E T H o d s
Patients
Eleven patients diagnosed with HCL were included in 
the study (see table 1 for clinical characteristics). Two of 
these patients had a mycobacterial infection at clinical 
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presentation. These patients had completely recovered from 
this infectious episode at the time of the present study. 
Patients had been treated previously with either cladribine 
(2-CDA), IFNα or a combination of both. Medication was 
stopped at least two weeks prior to the assessment of 
cytokine production. All samples were obtained between 
9 am and 11 am, and for each patient, two gender-matched 
volunteers were concomitantly tested (n=22, 20 men and 
2 women, age 26 ± 7 years).
Ex-vivo stimulation of cytokine production
After obtaining informed consent, venous blood was drawn 
from the cubital vein of patients and healthy volunteers into 
three 10 ml EDTA tubes (Monoject). Isolation of mononuclear 
cells (MNC) was performed as described,9 with minor 
modifications. The MNC fraction was obtained by density 
centrifugation of blood diluted 1:1 in pyrogen-free saline over 
Ficoll-Paque (Pharmacia Biotech). Cells were washed twice 
in saline and suspended in culture medium (RPMI 1640 
DM) supplemented with gentamicin 10 μg/ml, L-glutamine 
10 mM and pyruvate 10 mM. The cells were counted in a 
Coulter counter (Coulter Electronics) and the number was 
adjusted to 5 x 106 cells/ml. The MNC population consisted of 
approximately 80% lymphocytes and 20% monocytes, and no 
differences between patients and controls were apparent.
5 x 105 MNC in a 100 μl volume were added to round-bottom 
96-well plates (Greiner) and incubated with either 100 μl 
of culture medium (negative control), or one of the various 
stimuli: 10 ng/ml LPS (S. typhimurium; Sigma Chemical), 
or 1 x 106 microorganisms/ml heat-killed (30 min, 100°C) 
S. typhimurium, Staphylococcus aureus, Mycobacterium 
tuberculosis or Candida albicans. After 24 hours (TNF, 
IL-1β and IL-6) or 48 hours (IFNγ) incubation at 37°C, 
supernatants were collected and cytokine concentrations 
were measured using specific ELISA kits (Pelikine, 
Sanquin, Amsterdam).
statistical analysis
The experiments were performed in duplicate with blood 
obtained from patients and volunteers, and the data are 
presented as cumulative results of all experiments performed. 
The differences between groups were analysed by the 
Mann-Whitney U test. The level of significance between 
groups was set at p<0.05. The data are given as means ± SD.
r E s U l T s  A N d  d i s C U s s i o N
When MNC of HCL patients were stimulated with LPS or 
a panel of microorganisms, the IFNγ production after 48 
hours of stimulation was significantly lower compared with 
healthy volunteers (figure 1A). In contrast, the production of 
the proinflammatory cytokines TNFα, IL-1β and IL-6 did not 
differ between HCL patients and controls (figure 1B-D). The 
specific defect in IFNγ production, in contrast to the normal 
synthesis of monocyte products such as TNFα, IL-1β and IL-6, 
suggests a selective T/NK-cell defect in HCL patients, and is 
not part of a more general defect in cytokine production. It 
is tempting to assume that such defective production also 
occurs in vivo and underlies the remarkable susceptibility of 
HCL patients to facultative intracellular pathogens.
Our finding that TNFα production is normal is remarkable, 
since elevated serum concentrations of TNFα have been 
reported in patients with HCL.10,11 As far as we know, 
defective IFNγ production has not been reported previously, 
despite the fact that there is extensive literature on 
T-lymphocyte abnormalities in this disorder.4-7 Cytokine 
gene expression in patients with HCL has been reported 
Table 1. Clinical characteristics of the 11 patients with hairy cell leukemia (HCL)
Patient Gender Year of diagnosis HCl therapy Mycobacterial 
infections
Monocytes (x 103/ml)
1 M 1987 IFNα No 70
2 M 1983 IFNα
2-CDA
No 56
3 M 1994 2-CDA No 232
4 M 1992 IFNα No 106
5 M 1984 Splenectomy
IFNα No 803
6 M 1995 2-CDA Mycobacterial 
lymphadenitis
324
7 M 1996 IFNα No 128
8 F 2000 IFNα
G-CSF
Disseminated
M. kansasii
117
9 M 1986 IFNα No 264
10 M 2000 2-CDA No 406
11 M 1983 Splenectomy
IFNα
No 690
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by Kluin-Nelemans et al.4 These authors investigated 
cytokine mRNA in T-cell fractions from spleens of HCL 
patients, and found spontaneous gene expression for IFNγ 
IL-2, IL-4 and granulocyte-macrophage colony stimulating 
factor (GM-CSF). Their finding of increased IFNγ mRNA in 
spleen and our report of strongly decreased IFNγ production 
may suggest that there is either a translational defect in 
these T cells, or a compartimentalised IFNγ production. 
Further studies are needed to elucidate this issue.
Decreased IFNγ production as a likely explanation for 
infections caused by facultative intracellular microorganisms, 
such as mycobacteria, has been reported for a number 
of conditions. First of all, there are hereditary disorders 
of the IL-12/IFNγ axis.12,13 In CD4 lymphopenia, either 
as a consequence of HIV infection or idiopathic, IFNγ 
production is low due to the loss of CD4 cells.14,15 In addition, 
in hyperIgE syndrome (HIES/Job’s syndrome), deficient 
IFNγ production has been found when blood cells were 
stimulated with relevant microbial stimuli (Staphylococcus 
and Candida spp.).16,17 It should be noted that in these 
patients, the susceptibility to infection pertains to the 
pathogens mentioned, rather than to facultative intracellular 
pathogens.18 A similar finding has been described in chronic 
mucocutaneous candidiasis.19 Finally, anti-TNFα treatment in 
patients with rheumatoid arthritis may lead to deficient IFNγ 
production and infections by both facultative intracellular 
pathogens and pyogenic microorganisms.20 A consequence 
of our finding is that recombinant IFNγ treatment may be 
considered for patients with HCL suffering from serious 
infection, with facultative intracellular microorganisms.
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figure 1. Cytokine production capacity in hairy cell leukemia (HCL)
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PbMC from healthy volunteers (n=22, open bars) and HCl patients (n=11, closed bars) were stimulated with lPs (10 ng/ml), or heat-killed  
S. typhimurium, S. aureus, M. tuberculosis, or C. albicans. The cytokine concentrations were measured in the supernatant after 48 hours (ifNγ) or  
24 hours (TNf, il-1β, and il-6). The data are expressed as means ± sd, *p<0.05.
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